Skip to main content

Table 1 The clinical characteristics at baseline

From: Effects of statin therapy on chronic kidney disease patients with coronary artery disease

Variables

CKD + CAD

CKD

P a

(n = 128)

(n = 126)

Characteristics

 Age (years)

69.7 ± 8.4

53.6 ± 17.8

< 0.001

 Male

90/128 (70.3)

54/126 (42.8)

< 0.001

 BMI (kg/m2)

24.3 ± 2.1

23.4 ± 2.2

0.001

 Hypertension

95/128 (74.2)

71/126 (56.3)

0.003

 Diabetes mellitus

34/128 (26.5)

36/126 (28.5)

0.72

 Smoking

58/128 (45.3)

21/126 (16.6)

< 0.001

 Myocardial infarction

72/128 (56.2)

0/126 (0)

< 0.001

 Angina pectoris

51/128 (39.8)

0/126 (0)

< 0.001

 Stroke

7/128 (5.4)

6/126 (4.7)

0.798

Medications

 Calcium-channel blocker

45/128 (35.1)

64/126 (50.7)

0.012

 ACEI

57/128 (44.5)

23/126 (18.2)

< 0.001

 ARB

46/128 (35.9)

66/126 (52.3)

0.008

β-blocker

92/128 (71.8)

37/126 (28.6)

< 0.001

 Loop diuretic

19/128 (14.8)

11/126 (8.7)

0.131

 Aspirin

117/128 (91.4)

37/126 (29.3)

< 0.001

 Statin

116/128 (90.6)

58/126 (46.0)

< 0.001

  1. Data are presented as mean ± SD or the number and its percentage (%). Percentage = the number of each individual category divided by n
  2. CAD coronary artery disease, CKD chronic kidney disease, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin-receptor blocker, BMI body mass index
  3. a indicates the comparison of mean or percentage between CKD + CAD group and CKD group